Private equity’s role in healthcare is changing. Alongside traditional acquisitions, private equity firms and PE-backed companies are increasingly using joint ventures, management arrangements, real estate transactions, minority investments, and other structures to expand their reach and influence over healthcare providers.
This page brings together research and resources discussed during Beyond the buyout: How healthcare policy can keep pace with private equity, including PESP’s research on joint ventures between private equity-backed companies and nonprofit health systems, policy options for states responding to increasingly complex ownership structures, and tools for tracking private equity investments across healthcare.
Featured resources
Private equity and nonprofit healthcare joint ventures
PESP’s research examines the growing use of joint ventures between private equity-backed companies and nonprofit health systems, including how these partnerships are structured, where they are operating, and the implications for patients, workers, and communities.
State policy approaches to private equity in healthcare
A resource for lawmakers and advocates examining ways states can strengthen oversight of private equity in healthcare, including transaction review, ownership and control, management relationships, and financial practices such as hospital sale-leasebacks.
More healthcare research and tracking tools
Explore additional resources on private equity ownership and investment in healthcare:
- Private Equity Hospital Tracker
- PESP healthcare research
- Private Equity Healthcare Bankruptcy Tracker
- Healthcare acquisition tracker
- Medicaid resources
- PACE Investment Tracker
- Brown University Private Equity State Tracker
About the webinar
The webinar brings together researchers, policymakers, and workers to look at how private equity healthcare investment is evolving, what these ownership structures can mean for patients and workers, and how policy can account for forms of control that may not look like a traditional acquisition. The goal is to give lawmakers and advocates information they can use as states consider healthcare transaction review, ownership disclosure, corporate practice of medicine protections, and other forms of oversight.



